Development pipeline developing well
https://www.nzx.com/announcements/325037
Of interest to me was the (continued) bigly increase in planned or consented units and beds pipeline:
FY16: 187
FY17: 907
FY18: 1099
Today (less than half way through FY19):1379 units/beds (less than 40% of those are that low margin [but crucial to attract residents] needs based stuff)
With a similar (net) development pipeline, a sort of similar post development portfolio (units/beds wise), ARV should really be at least as exciting as OCA... looking forward to 1H19 results out in the next month ish.
Yet 4 years on from listing, and a track record of increasing EPS, ARV is still the dog (and the cheapest) of the listed retirement stocks.
Lucky ARV aren't going too big into care suites, I believe there has been some push back against them